STOCK TITAN
  1. Home
  2. Sec-filings
  3. REVB
  4. [EFFECT] REVELATION BIOSCIENCES, INC. SEC Filing

[EFFECT] REVELATION BIOSCIENCES, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 11, 2026 4:00 P.M.
Form: S-3
CIK: 0001810560
Company Name: REVELATION BIOSCIENCES, INC.
File Number: 333-293078

Source: View Original Filing on SEC EDGAR

Stock REVB logo
Revelation Biosciences

NASDAQ:REVB

REVB Rankings

#6739 Ranked by Market Cap
N/A Ranked by Dividends

REVB Latest News

Jan 26, 2026
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
Jan 23, 2026
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
Jan 21, 2026
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
Jan 14, 2026
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
Jan 12, 2026
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

REVB Latest SEC Filings

Feb 11, 2026
[424B3] REVELATION BIOSCIENCES, INC. Prospectus Filed Pursuant to Rule 424(b)(3)
Feb 6, 2026
[PRE 14A] REVELATION BIOSCIENCES, INC. Preliminary Proxy Statement
Feb 5, 2026
[Form 4] REVELATION BIOSCIENCES, INC. Insider Trading Activity
Feb 5, 2026
[Form 4] REVELATION BIOSCIENCES, INC. Insider Trading Activity
Feb 5, 2026
[Form 4] REVELATION BIOSCIENCES, INC. Insider Trading Activity

REVB Stock Data

4.04M
996.13k
0.9%
1.67%
13.52%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO